ConfirmPDX - First-to-market ddPCR assay to better understand tumor composition

No more estimating. No more ranges. No more uncertainty.

When PDX models are transplanted into mice, human tumors can become contaminated with mouse cells, making it difficult to assess the impact of your treatment on a human tumor.

Lack of visibility into your results can diminish confidence in your therapeutic trials, reducing the likelihood of qualifying for human clinical trials.

In this webinar, you’ll have the chance to learn about ConfirmPDX, a new solution that improves the precision of your cell line characterizations so that you can move your research forward with confidence.

 

Meet the presenters

Sarah A. Hansen
DVM, MS, DACLAM

Scientific Affairs

Steve Smith
Ph.D, MBA

Senior Product Manager, Biologics

Fast, accurate, and reliable results from the team you know and trust.

Connect with IDEXX BioAnalytics today.